View More Recent Stories
-
Amgen (AMGN) Suit No Surprise for Regeneron (REGN) - Analyst (SNY)
-
Regeneron Pharma (REGN) Eylea DME Efficacy Data Better Than Anticipated, Says RBC
-
Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded
-
Notable Analyst Rating Changes 02/12: (CROX) (S) (ZTS) Upgraded; (AMZN) (DF) (GMCR) Downgraded
-
RBC Capital Maintains an 'Outperform' on Regeneron Pharma (REGN); Agreement With Roche Better Than Expected
-
RBC Capital Upgrades Regeneron Pharma (REGN) to Outperform
-
Morning Movers 04/29: (SPWRA) (NTGR) (ACOM) (ASGN) Higher; (KVHI) (SUNH) (KND) (RIMM) Lower
-
RBC Capital Downgrades Regeneron Pharma (REGN) to Sector Perform
-
RBC Capital Upgrades Biogen (BIIB), Regeneron (REGN) to Outperform, Downgrades Celgene (CELG) to Sector Perform

